| 34.96 -0.277 (-0.79%) | 02-20 10:01 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 42.84 | 1-year : | 44.5 |
| Resists | First : | 36.68 | Second : | 38.1 |
| Pivot price | 35.28  |
|||
| Supports | First : | 34.38 | Second : | 28.6 |
| MAs | MA(5) : | 34.88  |
MA(20) : | 35.77 |
| MA(100) : | 35.49 |
MA(250) : | 30.86 |
|
| MACD | MACD : | -0.6 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 22.7 |
D(3) : | 17.4 |
| RSI | RSI(14): 39.7 |
|||
| 52-week | High : | 38.16 | Low : | 23.64 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ HELX ] has closed above bottom band by 38.7%. Bollinger Bands are 8.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 35.27 - 35.48 | 35.48 - 35.66 |
| Low: | 34.06 - 34.29 | 34.29 - 34.48 |
| Close: | 34.64 - 35 | 35 - 35.32 |
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
Thu, 19 Feb 2026
The Technical Signals Behind (HELX) That Institutions Follow - Stock Traders Daily
Sun, 08 Feb 2026
Precision Trading with Franklin Genomic Advancements Etf (HELX) Risk Zones - Stock Traders Daily
Mon, 24 Nov 2025
Best-Performing ETFs of Last Week: Healthcare Rules - Nasdaq
Fri, 21 Nov 2025
Inside the Recent Strength in Biotech ETFs - Zacks Investment Research
Sun, 20 Apr 2025
IDNA: The Cutting Edge Of Medical Science Is A Risky Investment (NYSEARCA:IDNA) - Seeking Alpha
Tue, 07 Mar 2023
Franklin forges ahead with legal battle over gold ETF - Citywire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
CBOE
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|